Browsing: Disease Area > Hematologic
A stem cell transplant is just the beginning of a patient’s journey towards recovery. After they leave hospital, they can face a huge range of challenges. In this video we speak with Amelia Chong to explore Anthony Nolans, ‘Who Cares?’ campaign which is calling for an urgent review of the care that patients receive after a stem cell transplant.
We spoke with a key study investigator of the multiple myeloma ENDEAVOR trial to explore the trial in more detail and to discover the potential clinical application of its overall survival findings.
Drugs used to treat heart and blood vessel problems have shown promise in combination with chemotherapy for acute myeloid leukemia treatment.
In this interview we explore the policy surrounding stem cell transplantation including high-profile projects such as the Defend Second Transplants campaign and find out ways to diversify the stem cell donor register to ensure that charities such as Anthony Nolan can provide the best donor match to individuals with blood cancer.
Discover the economic burden of allogeneic hematopoietic stem cell transplant in acute lymphoblastic leukemia pediatric patients in this research article from our partnered journal, the International Journal of Hematologic Oncology.
In this review, gaps and limitations in pharmacogenomics in pediatric acute lymphoblastic leukemia are emphasized, which may provide a useful guide for future research design.
Researchers have demonstrated a previously undefined role of histone deacetylase 11 (HDAC11), in regulating T-cell effector functions.